Skip to main contentSkip to article\nBrought to you by:Iowa State University Library\nMy…
- User
Skip to main contentSkip to article\nBrought to you by:Iowa State University Library\nMy account\nOutline\nCited by (68)\nFigures (4)\nTables (1)\nMicrobes and Infection\nVolume 2, Issue 8, July 2000, Pages 965-972\nReview\nPathogenicity of Erysipelothrix rhusiopathiae: virulence factors and protective immunity\nAuthor links open overlay panel\nhttps://doi.org/10.1016/S1286-4579(00)00397-XGet rights and content\nUnder an Elsevier user license\nopen archive\nAbstract\nErysipelothrix rhusiopathiae is the causative agent of erysipelas in animals and erysipeloid in humans.\n\nIn the absence of specific antibodies, the organism evades phagocytosis by phagocytic cells, but even if phagocytized, it is able to replicate intracellulary in these cells.\n\nIn this review, recent advances in our understanding of the pathogenicity of E. rhusiopathiae and its protective immunity are described.\n\nKeywords\nErysipelothrix rhusiopathiae\npathogenicity\ncapsule\nopsonic antibody\ncell-mediated immunity\n1.\n\nIntroduction\nErysipelothrix rhusiopathiae, the causative agent of erysipelas, is a Gram-positive, non-spore-forming, non-acid-fast, rod-shaped bacterium.\n\nE. rhusiopathiae is classified in the genus Erysipelothrix together with E. tonsillarum and two other unnamed species [1].\n\nE. rhusiopathiae is ubiquitous in nature and has been isolated from many species of wild and domestic mammals and birds as well as reptiles, amphibians, and fish [2].\n\nThe organism causes a variety of diseases in many species of birds and mammals, including humans, but it is most important as the causative agent of swine erysipelas [2].\n\nSwine erysipelas usually results from ingestion of contaminated food or water.\n\nIt has been reported that approximately 30–50% of apparently healthy swine carry the organism in their tonsils and other lymphoid tissues of the alimentary canal, and such bacteria in the tissues are thought to gain entry to the deeper body tissues or bloodstream [2].\n\nSwine erysipelas may occur as an acute septicemic disease or chronic disease typically characterized by endocarditis and polyarthritis [2].\n\nThe chronic arthritis in swine resembles rheumatoid arthritis in many respects, making erysipelas polyarthritis an interesting model for studying the pathomechanisms of chronic inflammation.\n\nIt also causes polyarthritis in sheep and lambs and serious death losses in turkeys.\n\nIn humans, the organism causes erysipeloid, a local cutaneous lesion usually on the fingers or hands, and rarely causes endocarditis or acute septicemic disease [2], [3].\n\nThe vaccine against swine erysipelas was first developed by Pasteur and Thuillier in 1883, and live attenuated vaccines or bacterins have long been used to control the disease in pigs and turkeys; however, the mechanisms of the pathogenicity of the organism and the basis of acquired protective immunity remain poorly understood.\n\nThe application of modern genetic methods have only recently provided new insights into them, and it was revealed that E. rhusiopathiae has a capsule which is important in regard to its virulence.\n\nThis article reviews the pathogenesis of E. rhusiopathiae infection, focusing on the capsule, and describes the mechanisms of protective immunity against infection.\n\n2.\n\nVirulence factors\n2.1.\n\nNeuraminidase and hyaluronidase\nE. rhusiopathiae produces various enzymes which have been suggested to be involved in the pathogenicity of bacteria.\n\nThe organism produces neuraminidase (sialidase) which can release terminal sialic acid residues from glycoproteins, glycolipid, and oligosaccharides expressed on host cells.\n\nIn a study of mice and pigeons that had been subcutaneously inoculated with virulent E. rhusiopathiae strain, it was shown that the injected bacteria were usually intracellular of endothelial cells lining the veins and capillaries and in endothelial cells free in the bloodstream [4].\n\nMüller and Krasemann [5] demonstrated a correlation between the virulence of E. rhusiopathiae strains and the amount of neuraminidase produced, and showed that antibodies to the enzyme are protective in mice, suggesting a role of the enzyme in adherence or antiphagocytic function.\n\nNakato et al.\n\n[6], [7] reported that neuraminidase may be involved in the pathogenesis of arteritis and thrombocytopenia in rats experimentally infected with the organism.\n\nThey observed that in vivo distribution of bacterial invasion was always concomitant with that of desialated sites of arterial regions, and that in vitro adhesion of bacteria to aortic endothelial cells was inhibited by addition of N-acetylneuramin-lactose, a substrate of bacterial neuraminidase.\n\nThus, it was demonstrated that neuraminidase of E. rhusiopathiae plays an important role in bacterial attachment and the subsequent invasion into host cells.\n\nThe organism also produces hyaluronidase, a spreading factor which facilitates the dissemination of pathogens into tissues.\n\nThe importance of the enzyme in the pathogenesis of the infection has been suggested by Mann [8].\n\nHowever, Nørrung [9] examined the virulence and hyaluronidase production of 62 isolates from joints or regional lymph nodes of pigs with arthritis, and concluded that there was no association between the organisms′ hyaluronidase production and their virulence.\n\nThus, the role of the enzyme in the pathogenesis of the infection remains controversial.\n\nTo clarify the role of hyaluronidase in virulence, transposon mutagenesis with Tn916 was used to construct mutants deficient in hyaluronidase production.\n\nApproximately 10 000 transposon mutants were generated from a highly virulent strain, E. rhusiopathiae Fujisawa-SmR, and screened for loss of hyaluronidase production.\n\nThe results showed that the virulent Fujisawa-SmR strain generated hyaluronidase-negative mutants at a high frequency, with this generation correlating with a change in colony morphology; colonies of the mutants displayed circular flat edges in contrast to those of the parent strain, which were convex and irregular in shape [20].\n\nInterestingly, most of the hyaluronidase-negative mutants were avirulent for mice, but one hyaluronidase-negative mutant (AST121) which had the same colony morphology as the parent strain, although it had two copies of Tn916 in the chromosome, exhibited the same level of virulence for mice as its parent strain.\n\nIt was later discovered that all of the avirulent mutants had also lost their capsules (refer to section 2.3), whereas the highly virulent mutant (AST121) still possessed the capsule (unpublished data).\n\nThese results raise the possibilities that both hyaluronidase and capsule production may be regulated by a common genetic locus, and that in these hyaluronidase-negative mutants, with the exception of AST121, insertion of Tn916 occurred in this regulatory region, resulting in the loss of both hyaluronidase and capsule production (phenotypes of the transposon mutants are summarized in table I).\n\nThus, the data suggested that the lack of virulence of most of the hyaluronidase-negative mutants could be attributed to a loss of the capsule, and that hyaluronidase is not essential for the pathogenesis of infection in mice.\n\nHowever, since the organism causes a variety of diseases other than septicemia, the enzyme may be important in the pathogenesis of infection in other hosts.\n\nTable I. Phenotypes of E. rhusiopathiae strains.\n\nStrain Hyaluronidase Capsule Virulence for mice Parent Fujisawa-SmR + + Virulent Mutant AST121 – + Virulent 47B12 – – Avirulent 566 – – Avirulent 736 – – Avirulent 942 – – Avirulent 293 – – Avirulent 33H6 + – Avirulent\n2.2.\n\nSurface proteins of E. rhusiopathiae\nSurface proteins of Gram-positive bacteria play pivotal roles in virulence, interacting in various ways with the environment in the host [10].\n\nTakahashi et al.\n\n[11] reported that a heat-labile and trypsin-sensitive surface component(s) of E. rhusiopathiae is important in bacterial adherence to host cells; however, this component has not yet been identified.\n\nIn E. rhusiopathiae bacteria, only a few surface proteins have been defined.\n\nLachmann and Deicher [12] have shown that the 66- to 64-kDa antigen and its 43-kDa derivative in cell surface extracts solubilized with detergents are the most prominent antigens reacting with a rabbit antiserum against heat-killed E. rhusiopathiae.\n\nThe surface location of these antigens was demonstrated, but the role of the antigens in virulence has not been tested.\n\nGálan and Timoney [13] identified and cloned a 5.4-kb EcoRI DNA fragment containing a protective gene from a virulent strain.\n\nThey found that guinea pig antiserum raised against the recombinant clones is reactive with the 66- to 64-kDa and 43-kDa antigen in Triton X-100 extracts and that these antigens are expressed less on strains of low or moderate virulence than on highly virulent strains.\n\nHowever, neither the DNA sequence of the gene nor the function of this protein was described.\n\nSpaA protein, a protective antigen of E. rhusiopathiae, is also a surface protein [14], [15].\n\nIn strain Fujisawa (serovar 1a), spaA encodes a mature protein with a molecular mass of 69 kDa [15].\n\nSpaA is very similar in its structure and the amino acid sequences of its C-terminal region to those of choline-binding proteins [16], [17], [18] of Streprococcus pneumoniae.\n\nThese results imply that SpaA, like the Streptococcus proteins, also plays a specific role in virulence; however, this role also remains to be elucidated.\n\nRecently, Makino et al.\n\n[19] cloned the gene encoding a surface protein with a molecular mass of 19 kDa.\n\nIt was shown that this protein itself has no haemolytic activity, but when cloned in Escherichia coli, it facilitates the haemolytic activity of the host bacterium.\n\nNeither the function nor the role in the virulence of this protein are known, however.\n\n2.3.\n\nCapsule\n2.3.1.\n\nResistance to phagocytosis\nLachmann and Deicher [12] first reported that E. rhusiopathiae has a capsule and that it may be important in the pathogenesis of infection.\n\nThey analyzed the surface components of the organism by sulfate-polyacrylamide gel electrophoresis and immunoblotting, and concluded that the major nonprotein antigen with a molecular mass of 14 000 to 22 000 is the capsular polysaccharide antigen.\n\nTo study the potential role of the capsule in virulence, Tn916-generated mutants which changed colony morphology on agar plates were selected and examined by electron microscopy for their cell surface structure and virulence in mice [20].\n\nElectron microscopy studies demonstrated the presence of an external layer resembling a capsule on the parent strain (Fujisawa-SmR)(figure 1), as well as its absence on all the mutants.\n\nThese mutants were found to be totally avirulent for mice (10 000-fold increase in intraperitoneal 50% lethal dose [LD50]), suggesting that the capsule structure on the cell surface is responsible for the virulence.\n\nPhagocytosis assay studies revealed that, in the presence of normal serum, the virulent parent strain resisted phagocytosis by murine polymorphonuclear leukocytes (PMNs), whereas all the mutants were susceptible to phagocytosis(figure 2).\n\nFurthermore, a revertant strain resisted phagocytosis and reverted to virulence following acquisition of the capsule when the transposon was lost by spontaneous excision.\n\nIt was revealed that the avirulent mutants are devoid of the capsular antigen, whereas the revertant strain expresses the antigen as does the parent strain (unpublished data).\n\nThus, it was found that the virulence of E. rhusiopathiae is at least associated with resistance to phagocytosis by PMNs and that this property is a function of the capsule.\n\n2.3.2.\n\nIntracellular survival\nEarly studies reported by Timoney [21], [22] have provided evidence of the importance of intracellular survival of E. rhusiopathiae within professional phagocytes for pathogenicity of the organism.\n\nIn these studies, a significant number of virulent E. rhusiopathiae bacteria survived within macrophages from unimmunized mice and within PMNs of pigs affected with erysipelas polyarthritis.\n\nTo examine whether the capsule of the organism plays a role in mediating intracellular survival, phagocytosis by murine macrophages and subsequent intracellular survival were examined [23].\n\nPhagocytosis assay studies showed that although enhanced phagocytosis was observed in the presence of immune serum, the virulent E. rhusiopathiae Fujisawa-SmR strain and its acapsular mutants were both ingested even in the presence of normal serum; however, the number of ingested bacteria was three- to fourfold greater in the case of the acapsular mutants than in the case of the parent strain, showing that, relative to the mutants, the virulent strain resists phagocytosis by macrophages.\n\nIn the presence of normal serum, the phagocytosis index of macrophages for the virulent Fujisawa-SmR strain was 35 times greater than that of PMNs.\n\nThese results are consistent with other studies of mice and pigeons [4], and of swine [24], [25], in which phagocytosis of the bacteria was carried out primarily by macrophages, not PMNs.\n\nThe reason for the difference in these cells′ ability to phagocytize the organism is currently unknown.\n\nThus, it was found that even in the presence of normal serum, macrophages can phagocytize the virulent parent strain to some extent.\n\nTo further examine whether the E. rhusiopathiae bacteria ingested by macrophages can survive and replicate within the cells, an intracellular killing assay was performed.\n\nThe results showed that when ingested in the presence of normal serum, the number of viable virulent parent (Fujisawa-SmR) bacteria decreased only minimally during the first 2 h and then began to multiply, with an approximately twofold increase at 3 h of incubation.\n\nIn contrast, the numbers of the mutant strains decreased significantly during the observation period.\n\nWhen ingested in the presence of immune serum, both the parent and mutant strains were readily killed.\n\nIt was found that the virulent parent strain ingested by PMNs in the presence of normal serum also survives and replicates intracellulary (unpublished data).\n\nAn electron micrograph obtained 6 h after infection showed that the virulent Fujisawa-SmR strain vigorously replicates within phagocytic cells in vivo, as visualized by the presence of many morphologically intact organisms, some of which are undergoing division(figure 3).\n\nThus, it was revealed that in the presence of normal serum, the virulent Fujisawa-SmR strain, but not the acapsular mutants, ingested by macrophages or PMNs survives and replicates within these professional phagocytic cells.\n\n2.3.3.\n\nIntracellular survival strategies\nWhat is the strategy by which E. rhusiopathiae evades the bactericidal activities of phagocytic cells?\n\nTo test the hypothesis that, in the presence of normal serum, the virulent parent strain does not stimulate phagocytic cells during phagocytosis, oxidative burst responses of macrophages were examined by monitoring chemiluminescence (CL) responses to E. rhusiopathiae strains [23].\n\nThe results showed that when macrophages were incubated with the bacteria preopsonized with normal serum, the CL response was much lower for the parent strain than for the mutant strains, but when macrophages were incubated with the bacteria preopsonized with immune serum, both the parent and the mutant stains induced a strong CL response.\n\nSince CL responses provide no information with regard to the responses of individual cells to the bacteria, an intracellular nitro blue tetrazolium (NBT) reduction assay, in which NBT is reduced by reactive oxidative metabolites to a visible intracellular formazan precipitate, was performed.\n\nAfter it was confirmed that most of the cell-associated bacteria were internalized by macrophages, the percentage of formazan-stained bacteria was determined microscopically.\n\nThe results showed that in the presence of normal serum, 84% of the ingested acapsular mutants were formazan stained, versus 26% of those of the parent strain.\n\nIn the presence of immune serum, most of the parent and mutant strains in the cells were formazan stained.\n\nFigure 4 shows the differences between the parent and mutant strains in the presence of normal serum.\n\nIt was thus revealed that, when ingested in the presence of normal serum, the virulent Fujisawa-SmR strain does not induce reactive oxidative metabolites from macrophages.\n\nHow does the virulent E. rhusiopathiae strain resist inducing the oxidative burst from macrophages?\n\nAre the macrophages damaged or killed by infection with the virulent E. rhusiopathiae strain?\n\nIt was found that the macrophages that had phagocytized the virulent parent strain opsonized with normal serum could release vigorous oxidative metabolites in response to the stimulus with fresh serum-opsonized zymosam (unpublished data).\n\nThis suggests that infection with the virulent strain does not affect the viability of the macrophages.\n\nThere are at least two possible explanations, not necessarily mutually exclusive, for the reduced production of reactive oxidative metabolites when the virulent strain enters macrophages.\n\nFirst, E. rhusiopathiae may quench oxidative metabolites by enzymes such as superoxide dismutase (SOD) and catalase.\n\nE. rhusiopathiae produces SOD but not catalase.\n\nHowever, the results showing that the addition of exogenous SOD could not prevent the intracellular killing of the mutants by macrophages, and that both the parent and mutant strains produced SOD (unpublished data), suggest that the role of the enzyme in evading bactericidal mechanisms by oxidative metabolites may be limited.\n\nHowever, it is possible that once the mutants are ingested and, as described below, the macrophage becomes activated, the effect of SOD may not be detected.\n\nA second hypothesis is that receptors involved in phagocytosis of the virulent parent strain, in the presence of normal serum, do not stimulate the oxidative burst of macrophages, whereas those involved in phagocytosis of the mutant strain do.\n\nIt has been reported that the receptor used for phagocytosis may influence the intracellular fate of such bacteria as Salmonella spp.\n\n[26] and Listeria monocytogenes [27].\n\nIt has also been reported that the killing of organisms by phagocytes is closely related to the cell surface properties of the organism [28], [29], [30].\n\nThese findings strongly suggest that the intracellular fate of the organism is dependent upon the microbe′s surface molecules, which determine this fate either by themselves or by binding to specific host receptor(s) that can influence the host cell response.\n\nIn a similar fashion, in the absence of specific antibodies, virulent E. rhusiopathiae bacteria may use certain host receptor(s) for successful intracellular infection, and in such cases the capsule will directly or indirectly affect the ligand-receptor interactions that mediate phagocytosis of the bacteria.\n\nIt is recognized that several intracellular pathogens use the complement receptors to gain entry into phagocytic cells.\n\nBinding to these receptors is able to promote phagocytosis, but does not result in triggering of the oxidative burst that accompanies Fc gamma receptor (FcγR)-mediated phagocytosis [31], [32].\n\nThen, do virulent E. rhusiopathiae bacteria use complement receptors for entry into phagocytic cells?\n\nTimoney [33] reported the importance of complement in protection against E. rhusiopathiae infection in mice.\n\nIn this study, mice were decomplementated by injection of heat-aggregated sheep γ-globulin and challenged with the bacteria.\n\nThe results showed that the decomplementated mice died earlier than did normal control mice.\n\nFurthermore, when challenge bacteria were preopsonized with fresh mouse serum, the decomplementated mice survived a lethal challenge, and heat treatment of the mouse serum at 56 °C abolished its protective activity.\n\nThus, it appears that E. rhusiopathiae bacteria opsonized with complement components are easily killed by phagocytic cells and cleared from the host.\n\nIt has also been reported that E. rhusiopathiae Fujisawa strain activates the alternative pathway of the complement, resulting in opsonization with C3b [34] and presumably iC3b.\n\nHowever, the organism activates the alternative pathway of the complement system and exploits it for successful intracellular parasitism; this would certainly appear paradoxical.\n\nFurther, it has been reported that the protective activity of antiserum to E. rhusiopathiae for mice was found only in the IgG fraction, and not in the IgM fraction [35].\n\nAssuming that, after activation of the complement system (the classical pathway), IgM-mediated phagocytosis occurs depending exclusively on the use of complement receptors, it would seem that phagocytosis of the organism via complement receptors results in successful intracellular survival of the organism.\n\nWhether E. rhusiopathiae bacteria use complement receptors to invade the host macrophage should be examined in future studies.\n\n3.\n\nMechanism of acquired immunity\n3.1.\n\nRole of opsonic antibody\nIn erysipelas infection, both humoral and cell-mediated immunity play an important role in host defense.\n\nA protective role of the specific antibody in the infection has long been suggested by the fact that immunization with bacterins or treatment with antiserum is widely used for disease control [2].\n\nIt has also been shown that E. rhusiopathiae bacteria opsonized with immune serum were readily eliminated by PMNs [20], [36] and by macrophages [23].\n\nThese findings strongly suggest that the protective activity of immune serum is, as shown above, probably the opsonic activity of IgG antibodies in type I phagocytosis, in which FcγR which triggers oxidative burst and other important intracellular bactericidal mechanisms is mediated [37].\n\nIt was found that mice immunized with purified capsular antigen of E. rhusiopathiae were not protected from lethal challenge and that mAbs raised against purified capsular antigen were exclusively IgM isotypes (unpublished data).\n\nThus, the capsular antigen alone cannot be a protective antigen, indicating that molecule(s) on the cell surface other than the capsular antigen are important in inducing protective IgG antibodies.\n\nOne of such antigens on the bacterial cell surface is the SpaA antigen [14], [15].\n\nThis protein is found in all the strains of E. rhusiopathiae tested [14], suggesting that this is a species-specific protective antigen [38].\n\nIt has been demonstrated that antisera raised against purified SpaA protected mice from challenge with a homologous virulent strain [15].\n\nIt has also been shown that purified SpaA can elicit protection in pigs by inducing opsonic antibodies [39].\n\nThe protective epitope of SpaA has been shown to be located within the 20-kDa N-terminal segment, which is composed of amino acids 12 to 195 of SpaA [15].\n\nThis suggests that the N-terminal end region of the protein might be surface exposed, being extended into and through the capsule, demonstrating therefore that the antibodies to this region have opsonic activity.\n\nThe 66- to 64-kDa protein in Triton X-100 extracts of the organism is also a protective antigen [13], [40].\n\nAs already described, the protein has been suggested to be located on the cell surface, and mice immunized with a recombinant 66- to 64-kDa protein fused with β-galactosidase were partially protected [13].\n\nIn this study, however, whether this protein elicits opsonic protective antibodies was not investigated, leaving the possibility that it induces a cell-mediated immune response.\n\n3.2.\n\nCell-mediated immunity\nThe role of cell-mediated immunity in protection was demonstrated by the study using acapsular E. rhusiopathiae YS-1 strain [41].\n\nIn this study, the acapsular YS-1 strain was generated using a novel mechanism after Tn916 has excised from the chromosome of a transposon mutant 33H6, and its protective capability as a live vaccine was evaluated in mice.\n\nThe results showed that although the acapsular YS-1 strain was unable to persist in vivo (cleared within 72 h after immunization), it elicited a complete long-lasting protection in mice.\n\nIt was demonstrated that in the YS-1 immunized-mice, protective antibodies were elicited and spleen cells obtained at days 7, 14, and 21 postimmunization proliferated significantly in response to E. rhusiopathiae antigens, showing that specific cell-mediated immune response was induced.\n\nMoreover, at day 7 postimmunization, growth inhibition in liver and spleen of the antigenically unrelated intracellular parasite L. monocytogenes was observed in these mice, indicating that nonspecific resistance to heterologous bacteria had been induced.\n\nThis cross-protection has been known as an indicator of cell-mediated immunity in intracellular bacterial infection [42], [43], thus indicating that in the YS-1-immunized mice, both arms of the immune system contribute to immunity to E. rhusiopathiae infection.\n\nThe bacterial antigen(s) involved in inducing this cell-mediated immunity remains, however, unidentified.\n\n4.\n\nConclusion\nThe pathogenicity of E. rhusiopathiae appears to be related mostly to the intracellular survival properties of the bacterium.\n\nThe bacterium probably utilizes several different host cell receptors to gain access to the host intracellular niche.\n\nThe receptor-ligand interactions involved in entry into macrophages constitute a complex but provocative area of research.\n\nA clear understanding of the molecular basis of cell surface molecule(s) of the bacterium should enable investigators to identify the receptor(s) involved in entry of the organism into the cells, and to clarify the receptor-ligand interactions that decide the fate of the organism.\n\nAcknowledgements\nThe author gratefully acknowledges his colleagues, who made important contributions to this work.\n\nThis work was supported in part by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan.\n\n----------\nAs a professional microbiologist, create a concise and comprehensive Chinese scientific report on Erysipelothrix Spp. research based on the provided text, whether it's an article, post, conversation, or passage. Follow these guidelines:\n\n 1. Produce a detailed and in-depth report that remains clear and concise.\n 2. Focus on main ideas and essential information, removing any extraneous language.\n 3. Strictly rely on the provided text without adding external information.\n 4. Format the report in paragraphs for easy understanding.\n 5. Conclude with “[End of Notes, Message #X],” where “X” represents the total number of messages I’ve sent. Increment the message counter with each new message.\n 6. Use English for technical terms, industry terminology, proper nouns, and species names. After you finish, add the following words: {{{ I_finished_papa!!! }}} to the end of you answer
- Assistant
Erysipelothrix spp. 研究报告
简介
Erysipelothrix rhusiopathiae 是引起动物红斑 (erysipelas) 和人类红斑病 (erysipeloid) 的病原菌。该细菌是一种革兰氏阳性、无孢子、非酸性、杆状细菌,广泛存在于自然界,可从多种野生和家养哺乳动物、鸟类,以及爬行动物、两栖动物和鱼类中分离。E. rhusiopathiae 在多种家畜与鸟类中导致多种疾病,其中以导致猪红斑病最为重要。
致病性因子
E. rhusiopathiae 的致病性与其多种 virulence 因子有关,主要包括神经酰胺酶(neuraminidase)、透明质酸酶(hyaluronidase)及其胶囊结构。神经酰胺酶的生产与细菌的附着和抗吞噬功能相关,并在病理生理研究中显现出对细菌致病性的影响。虽然透明质酸酶被认为能促进细菌在组织中的扩散,但其在细菌致病性中的具体作用尚有争议。
胶囊与生存机制
E. rhusiopathiae 拥有胶囊结构,这被认为与其抵抗吞噬细胞的作用有关。研究显示,携带胶囊的细菌在吞噬细胞中能有效存活并复制,而无胶囊的突变株则在吞噬过程中被显著消灭。肺部巨噬细胞和多形核白细胞对该细菌的吞噬率不同,也间接表明了胶囊在其生存及致病性中的关键角色。
保护免疫机制
在感染 E. rhusiopathiae 的过程中,体液免疫及细胞免疫均扮演着重要角色。免疫血清中存在的特异性抗体显示出其在清除细菌中的作用,尤其是 IgG 抗体,在吞噬过程中促进细胞的氧化爆发。虽然胶囊抗原的存在未能提供保护作用,但细胞表面的一些其他抗原,如 SpaA 和 66-至 64-kDa 蛋白,均显示出良好的免疫保护潜力。
结论
E. rhusiopathiae 的致病性主要与其利用宿主细胞的内源性生存能力以及胶囊的存在有关。未来的研究应聚焦于阐明细菌表面分子与宿主细胞受体之间的相互作用,以更深入地揭示其病理机制和细胞免疫反应的特征。
[End of Notes, Message #1] {{{ I_finished_papa!!! }}}
- User
A combinational approach of multilocus sequence typing and other molecular typing methods in unravelling the epidemiology of Erysipelothrix rhusiopathiae strains from poultry and mammals\nDownload PDF\nDownload PDF\nA combinational approach of multilocus sequence typing and other molecular typing methods in unravelling the epidemiology of Erysipelothrix rhusiopathiae strains from poultry and mammals\nVeterinary Research volume 46, Article number: 84 (2015) Cite this article\n4394 Accesses\n34 Citations\n1 Altmetric\nMetrics details\nAbstract\nErysipelothrix rhusiopathiae infections re-emerged as a matter of great concern particularly in the poultry industry.\n\nIn contrast to porcine isolates, molecular epidemiological traits of avian E. rhusiopathiae isolates are less well known.\n\nThus, we aimed to (i) develop a multilocus sequence typing (MLST) scheme for E. rhusiopathiae, (ii) study the congruence of strain grouping based on pulsed-field gel electrophoresis (PFGE) and MLST, (iii) determine the diversity of the dominant immunogenic protein SpaA, and (iv) examine the distribution of genes putatively linked with virulence among field isolates from poultry (120), swine (24) and other hosts (21), including humans (3).\n\nUsing seven housekeeping genes for MLST analysis we determined 72 sequence types (STs) among 165 isolates.\n\nThis indicated an overall high diversity, though 34.5% of all isolates belonged to a single predominant ST-complex, STC9, which grouped strains from birds and mammals, including humans, together.\n\nPFGE revealed 58 different clusters and congruence with the sequence-based MLST-method was not common.\n\nBased on polymorphisms in the N-terminal hyper-variable region of SpaA the isolates were classified into five groups, which followed the phylogenetic background of the strains.\n\nMore than 90% of the isolates harboured all 16 putative virulence genes tested and only intI, encoding an internalin-like protein, showed infrequent distribution.\n\nMLST data determined E. rhusiopathiae as weakly clonal species with limited host specificity.\n\nA common evolutionary origin of isolates as well as shared SpaA variants and virulence genotypes obtained from avian and mammalian hosts indicates common reservoirs, pathogenic pathways and immunogenic properties of the pathogen.\n\nIntroduction\nErysipelothrix rhusiopathiae is a ubiquitous gram-positive bacterial organism which causes erysipelas in mammals and birds, especially in pigs and poultry.\n\nHealthy pigs carrying E. rhusiopathiae in their lymphoid tissues have been suggested as a reservoir of the pathogen [1].\n\nThe genus Erysipelothrix contains two main species: E. rhusiopathiae (including serotypes 1a, 1b, 2, 4, 5, 6, 8, 9, 11, 12, 15, 16, 17, 19, 21 and N) and E. tonsillarum (serotypes 3, 7, 10, 14, 20, 22 and 23), the latter being isolated from apparently healthy swine and considered to be non-pathogenic [1-4].\n\nE. rhusiopathiae was first recognized as a human pathogen causing localized cutaneous lesions, called erysipeloid, and sporadic cases of generalized cutaneous forms or septicaemia, often associated with endocarditis [2,5].\n\nErysipelas in swine occurs in different forms characterized by septicaemia often resulting in sudden death (acute form), cutaneous lesions (sub-acute form), polyarthritis and endocarditis (chronic form) [1,2,6].\n\nIn recent years, Erysipelas in poultry re-emerged and here, turkeys are most seriously affected and suffer from cyanotic skin to haemorrhages and petechiae in the breast and leg muscles.\n\nFollowing the change from conventional (battery) cage system to alternative housing systems, problems due to E. rhusiopathiae also increased in laying hen [2,6-12].\n\nWhile attenuated live vaccines and bacterins are commercially available to protect pigs and sheep, in Germany there is no licensed vaccine to prevent erysipelas in turkeys and laying hen and this is why the application of autogenous vaccines and/or antimicrobial therapy is the ultimate way to combat the disease [1,2,9].\n\nOne of the most promising vaccine candidates is SpaA, a surface protein with high immunogenic properties [13-16].\n\nBased on amino acid sequence similarities the Spa proteins can be classified into 3 molecular variants, termed SpaA, SpaB, and SpaC and the occurrence of these variants has been found to be basically associated with the serotype of a strain [14].\n\nParticularly the N-terminal half of the hyper-variable region of the Spa protein is important for specific immunity, and strains with different spaA gene variants obviously differ in pathogenicity [17].\n\nE. rhusiopathiae strains vary considerably in virulence but only little is known about pathogenic mechanisms and the presence and distribution of virulence factors [2].\n\nDifferent factors, including neuraminidase, capsule, hemolysin, hyaluronidase, adhesins and the cell wall lipoprotein EwlA have been suggested to be involved in the pathogenesis of the disease [2].\n\nThe availability of the genome sequence of E. rhusiopathiae strain Fujisawa (Acc.-No.\n\nAP012027.1) offers the opportunity for the in silico-identification of additional genes that have been linked with virulence in other bacterial species before.\n\nThe coding sequence ERH_1472 was for example annotated as internalin gene intI, which in case of Listeria monocytogenes contributes to the invasion of the bacteria into epithelial cells [18].\n\nVarious studies have been performed to determine the clonal relatedness of E. rhusiopathiae strains [19-25].\n\nData from multilocus enzyme electrophoresis (MEE) [20], restriction fragment length polymorphism (RFLP) analyses [19], amplified fragment length polymorphism (AFLP) [21], randomly amplified polymorphic DNA methods (RAPD) [23,25], and pulsed-field gel electrophoresis (PFGE) [22,24] suggested that E. rhusiopathiae strains might be genetically diverse even among isolates belonging to the same serotype.\n\nAlthough the relevance of Erysipelas in poultry increased over the last years, intense epidemiological studies on E. rhusiopathiae from poultry combining established typing methods such as PFGE, Spa typing and virulence gene typing are limited [10,22] Moreover, there is currently no established scheme to study this bacterial species by Multilocus sequence typing (MLST), a widely applied method to determine the phylogeny of a bacterial population based on sequence analysis of representative genes of the bacterial core genome [26].\n\nThe overall objective of this study was to provide a deeper insight into the population structure of E. rhusiopathiae by developing an MLST scheme and determining sequence types of 165 E. rhusiopathiae strains predominantly isolated from poultry and also from mammalian hosts, including few human strains.\n\nThe congruence of multilocus sequence types of individual strains with their grouping into PFGE clusters and their surface protective antigen (Spa) protein variant was evaluated and the distribution of 16 genes putatively linked with the pathogenic properties of the strains was investigated.\n\nMaterials and methods\nBacterial strains and species designation\nA total of 165 E. rhusiopathiae strains primarily from Germany (136) and from a few other countries (29) were included.\n\nThe major focus was on isolates from avian sources (chicken, 71; turkey, 43; other birds, 6), while isolates from pigs (n = 36) and other animal species (n = 6) and humans (3) were included as well.\n\nBacterial strains were isolated from organ and blood samples from diseased animals and from blood samples in case of the human strains.\n\nIn case of outbreak situations, only one strain per flock was sampled.\n\nStrains obtained from recurrent disease events in identical flocks were only included if six months had passed since the previous event or if they revealed different banding patterns, as initially determined by pulsed-field gel electrophoresis (data not shown).\n\nE. rhusiopathiae strains and the non-pathogenic species E. tonsillarum were differentiated by a species-specific PCR [27].\n\nReference strains E. rhusiopathiae ATCC 19414T, E. tonsillarum DSM 14972T (ATCC 43339T), and E. inopinata DSM 15511T as well as two field strains of E. tonsillarum were also included.\n\nThe reference strains were purchased from the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany).\n\nAll strains were stored at −80 °C in liquid medium (brain heart infusion broth) supplemented with 20% glycerol until used.\n\nDNA purification\nThe total DNA of E. rhusiopathiae was purified using a protocol described previously [28].\n\nInstead of using a 1.5 mL bacterial culture grown in BHI for 24 h, as recommended in the protocol, we took 20 mL of an overnight culture to obtain a higher amount of DNA.\n\nDNA concentration was determined by UV/VIS spectrophotometry (NanoDrop®ND1000 Spectrophotometer, Thermo Fisher Scientific).\n\nAliquots (20 ng/μL) were stored at −20 °C until further use.\n\nGenes for MLST and nucleotide sequencing of gene fragments\nTo establish an MLST scheme, genes were selected based on published protein sequences of E. rhusiopathiae, located in the published contigs of the reference strain E. rhusiopathiae ATCC 19414T (project ID: 38421), sequenced by the National Institute of Animal Health, Japan, in cooperation with the Dragon Genomics Center, Takara Bio Inc., Japan.\n\nBased on reversed translated protein sequences, primers were designed to amplify gene fragments of housekeeping genes gpsA (glycerol-3-phophate-dehydrogenase), recA (recombinase A), purA (adenylosuccinate synthetase), pta (phosphate acetyl-transferase), prsA (ribose-phosphate-pyrophosphokinase), galK (galactokinase), and ldhA (D-lactate dehydrogenase) (Table 1).\n\nGenes were chosen in line with MLST schemes for other bacteria taking into account (i) a gene size > 700 bp, (ii) a regular distribution of genes among the E. rhusiopathiae genome, and (iii) that predicted proteins should be under stabilizing selection.\n\nPCRs were performed in a volume of 60 μL containing 60 ng DNA template, 10 pmol of each primer (Sigma Alderich, Munich, Germany), 10 mM dNTP mixture, 10 × PCR buffer including 20 mM MgCl2, and 1 U Taq polymerase (all Rapidozym, Berlin, Germany).\n\nThe PCR conditions were initial denaturation at 95 °C for 3 min followed by 30 cycles of denaturation at 95 °C for 30 s, annealing at 55 °C for 30 s (except for galK, for which an annealing temperature of 54 °C was used), and extension at 72 °C for 1 min, with a final extension at 72 °C for 10 min.\n\nAmplicons were sequenced by LGC genomics (Berlin, Germany).\n\nSequence analysis was performed with Ridom SeqSphere 1.0.1 [29].\n\nEach unique sequence of a gene fragment was assigned an allele number.\n\nThese allele numbers were consecutively numbered and combined in order to establish an allelic profile, which defined the sequence type (ST).\n\nUsing the eBURST program [30] the MLST data set was divided into groups of related STs (clonal complexes resp.\n\nST complexes).\n\nWe used the most stringent definition of ST complexes, which were defined as groups when six out of seven alleles from the nearest neighbour were the same [31].\n\nThe program START version 2 [32], was used to determine the number of variable nucleotide sites and their effects on the amino acid sequence changes.\n\nThis was done by calculating the ratio of non-synonymous substitutions (d N ) to the number of synonymous substitutions (d S ) (d N /d S ratio) [33].\n\nThe d N /d S ratio quantifies the evolutionary pressure on proteins [34] and thus indicates the presence or absence of a selective force on the locus [35].\n\nSimpson’s index of Diversity (D) was calculated on the basis of the molecular pattern of the seven loci [36-38].\n\nA Simpson’s index of diversity with 95% confidence intervals (CI95%) was calculated for a set of 165 strains.\n\nA value close to 1 indicates high diversity, and a value close to 0 reflects little diversity.\n\nPulsed-field gel electrophoresis\nPulsed-field gel electrophoresis (PFGE) followed a previously published protocol [24] and was performed to group E. rhusiopathiae isolates according to their macrorestriction profiles.\n\nPFGE was also applied to discuss the discriminatory power and interpretative value of this band-based method compared with the sequence-based MLST analysis.\n\nThe chromosomal DNA was digested with SmaI (Fermentas Life Science, Germany).\n\nElectrophoresis was carried out in a contour-clamped homogeneous electric field (CHEF- DRIII; Biorad, Munich, Germany).\n\nMidRange PFG Marker I (BioLabs, #N3551S) was used as DNA size standard.\n\nBand patterns were analysed with the software BioNumerics (Version 6.6, Applied Maths, Belgium).\n\nDendrograms were created by an unweighted pair group matching by an arithmetic averages algorithm (UPGMA) and the Dice coefficient.\n\nOptimization was set at 0.9%, band position tolerance at 2.0% [39].\n\nTo compare the discriminatory power of MLST and PFGE the Simpson’s index of Diversity (D) was used [36-38].\n\nAn index of diversity close to 1 indicated a high diversity of the strain collection, whereas a value close to 0 suggested little diversity.\n\nWe calculated the Simpson’s index of diversity (D) with 95% confidence intervals (CI95%).\n\nDetection of virulence-associated genes by Multiplex PCR\nTwo multiplex PCR protocols were established to screen for genes putatively linked with the virulence of E. rhusiopathiae.\n\nThe selection of the genes was based on (i) previous studies, linking the gene products with a certain pathogenic mechanism [2,40-44] and (ii) publicly available annotation data of coding sequences of E. rhusiopathiae (Acc.-No.\n\nAP012027.1), determined by whole genome analysis [45] (see Table 2).\n\nThe sequences of oligonucleotide primers, either obtained from recent publications [14,46] or designed in the present study are given in Table 2.\n\nPCRs were performed in a T300 Thermocycler (Biometra, Göttingen, Germany).\n\nA 25 μL aliquot contained 3 μL of each of purified chromosomal DNA (20 ng), 20 pmol of each primer pair (Sigma Alderich, Munich, Germany), 5 mM of the four deoxynucleoside triphosphates (Rapidozym, Berlin, Germany), 10 × PCR buffer including 20 mM MgCl2, and 0.4 U Dream Green Taq DNA Polymerase (Thermo Fisher Scientific, St. Leon-Rot, Germany).\n\nPCR was performed under the following conditions: an initial denaturation step at 94 °C for 10 min followed by 30 cycles of denaturation at 94 °C for 1 min, annealing at 53 °C for 2 min, extension at 72 °C for 7 min, and finally one cycle of extension at 72 °C for 10 min.\n\nPCR products were separated by gel electrophoresis in a 1.5% agarose gel containing ethidiumbromid for 90 min at 120 V and analysed by gel documentation system (Easy doc, Herolab, Wiesloch, Germany).\n\nSequencing of spaA genes\nIn order to distinguish the three different molecular variants of the Spa protein [14] we performed restriction length polymorphism (RFLP) analysis and single locus sequence typing (SLST) of the spa gene.\n\nThe Spa type variant genes spaA, spaB and spaC were PCR amplified under standard PCR conditions (60 ng template DNA, 10 pmol each primer (Sigma Alderich, Munich, Germany), 10 × PCR buffer including 20 mM MgCl2, 5 mM dNTP mixture, and 0.5 U Dream Green Taq DNA Polymerase (Thermo Fisher Scientific, St. Leon-Rot, Germany), using primers Spa-fw (5′- ATGAAAAAGAAAAAACACCTA – 3′), located at position 1–21, and Spa-rv (5′- CTATTTTAAACTTCCATCGTT – 3′), located at position 1881–1862 of serotype 1a reference strain Fujisawa (Acc.-No.\n\nAP012027.1).\n\nThe cycling conditions were 5 min at 94 °C, followed by 30 cycles of 30 s at 94 °C, 30 s at 52 °C and 130 s at 72 °C.\n\nFinal extension was done at 72 °C for 10 min.\n\nAlignment of primers with publicly available spaB (Acc.-No.\n\nAB238211 - AB238215) and spaC (Acc.-No.\n\nAB238210) gene sequences of serotype 4, 6, 11, 19, 21, and 18 strains, respectively, revealed that they could amplify all known gene variants correctly.\n\nAmplicons were then digested with restriction enzyme HhaI overnight at 37 °C.\n\nSpa genes revealing different RFLP patterns were double-strand sequenced using the same primers as above and data were analyzed with RidomSeqSphere 1.0.1 [29] and the EditSeq and MegAlign programs of the DNAStar software package (DNASTAR Inc. Madison, Wisconsin, USA).\n\nAlignments of nucleotide and amino acid sequences were performed with RidomSeqSphere.\n\nResults\nMultilocus sequence typing\nAllele sizes for the genes included for MLST analysis of 165 E. rhusiopathiae strains ranged between 531 bp for ldhA to 640 bp for recA (Table 1).\n\nThe mean GC content varied from 36.6% (pta) to 40.3% (ldhA).\n\nAmong the 165 investigated isolates with the corresponding 3.995 bp of the concatenated sequences of seven loci, 75 (1.9%) variable sites were confirmed.\n\nThe number of alleles ranged from six for prsA to 14 for purA.\n\nThe nucleotide diversity within the single loci varied between four (0.7%) for prsA and 14 (2.6%) for ldhA, the diversity index (D) for each allele between 0.579 (pta) and 0.775 (recA).\n\nThe d N /d S ratio for all seven loci demonstrated to be < 1 (Table 1).\n\nThe combination of allele numbers and the corresponding sequence types are shown in Table 3.\n\nA list of all strains with their sequence types is available as additional file (see Additional file 1).\n\nOf 72 sequence types (STs) assigned to 165 E. rhusiopathiae isolates, more than half (58.3%) were singletons.\n\nThe remaining 29 STs were represented by two or more strains.\n\nST9 was by far the most common sequence type, which grouped 18 isolates (10.9%) from poultry (n = 12), pigs (n = 3), sheep (n = 1), and also from a case of wound infection and a case of endocarditis in humans together.\n\nSequence type 4 (n = 11 poultry isolates) and ST5 (n = 10 poultry and one pig isolate) were the second most frequent STs.\n\nOverall, eBURST analysis based on all allelic profiles revealed a highly divergent population structure among the E. rhusiopathiae strains under study (Figure 1).\n\nOnly one sequence type complex, i.e.\n\na group of phylogenetic related strains was identified.\n\nST complex 9 (STC9), named after its predicted founder, included 22 STs and accounted for 34.5% of the total collection of MLST-analysed strains.\n\nAs depicted in Figure 2A, 40 avian and 17 mammalian E. rhusiopathiae strains were among the STC9 strains.\n\nIn general, no host-specific or host-restricted sequence type was observed, as isolates from different hosts scattered around the various STs identified (Figure 2A).\n\nIn addition, different countries shared isolates with identical STs, e.g.\n\nST3 (isolates from Austria, Germany, Sweden), ST9 (Austria, Germany, USA), and ST19 (Estonia, Germany, USA), not suggesting any association between certain STs with distinct countries.\n\nHowever, due to a sample bias towards isolates from Germany, this should be verified by including a larger number of isolates from various countries.\n\nPulsed-field gel electrophoresis and comparison of sequence types with PFGE clusters\nBased on an 85% cut-off- value we identified 54 different PFGE clusters containing one (n = 17 singletons) to 13 strains among 165 E. rhusiopathiae isolates (Additional file 2).\n\nIdentical macrorestriction profiles were only rarely observed which is consistent with our criteria for strain selection, i.e.\n\nexclusion of copy strains from the analysis.\n\nIn contrast to PFGE, MLST revealed 72 different sequence types and, as expected, the grouping achieved by both methods revealed only partial congruence.\n\nThe most homogenous macrorestriction profile was observed for strains assigned to ST4.\n\nAll eleven ST4 strains, isolated from 1999 to 2011 from chickens and turkeys in Germany clustered exclusively together at a similarity value of 90.9% (Figure 3A).\n\nIn contrast, strains of the most prominent sequence type ST9 were distributed among 12 different PFGE clusters, including three singletons, with an overall similarity of 64.5% (Figure 3B).\n\nThese PFGE clusters frequently harboured strains of other sequence types as well, which is also the case for most of the other non-singleton PFGE clusters.\n\nA calculation of the Simpsons index of discriminatory (D) with 95% confidence interval (CI95%) revealed that the ability of MLST to discriminate E. rhusiopathiae isolates (D = 0.973; CL95% [0.963 to 0.983]) was similar to that of PFGE (D = 0.976; CL95% [0.970 to 0.982]).\n\nHowever, as exemplified by the dendrograms shown in Figure 3 and in the Additional file 2, strain groups established by the band-based method PFGE and the sequence-based method MLST frequently differ in their composition.\n\nVirulence gene typing\nHighly homogenous patterns of putative virulence genes were observed among the 165 E. rhusiopathiae isolates with 136 (82.4%) of them possessing all 16 investigated genes (Table 2).\n\nAnother 24 (14.5%) isolates differed only by the absence of internalin gene intI.\n\nFive isolates lacked either algI (n = 4), or dnaB (n = 1), which might be associated with colonization and resistance to phagocytosis and with bacterial proliferation and adhesion, respectively [45].\n\nNone of the 16 genes investigated were present in the E. inopinata reference strain DSM 15511T, whereas nanH and ewlA were detected in the E. tonsillarum strain DSM 14972T as well as in both field strains of E. tonsillarum.\n\nSpa typing\nSequence analysis of the amplified DNA fragments of spa genes revealed the consistent presence of spaA and the absence of spaB and spaC, respectively, among all 165 E. rhusiopathiae isolates.\n\nThe size of spaA open reading frames ranged from 1761 to 2181 bp (encoding 587 to 727 amino acids).\n\nThe signal sequences of 29 amino acids were conserved among the Spa proteins of 164 isolates (99.4%).\n\nOnly one isolate from a duck (IMT28342; Acc.-No.\n\nKR606269) showed a mutation at nucleotide position 27 (A to G) and at amino acid position 10 (Lysin to Glutamic acid), respectively.\n\nSequences of the N-terminal hypervariable region of the spaA gene of field isolates and of E. rhusiopathiae serotype reference strains were compared with that of the virulent wild-type reference Fujisawa serotype 1a strain (see Table 4).\n\nBased on patterns of amino acid changes at eight different positions, the field isolates were divided into five groups as follows: (i) 87 isolates with isoleucine at position 55 (Ile-55), Asn-70, Asp-178, Asn-195, Ile-257 and Gln-303 classified as group I, (ii) 36 isolates with Ser-101 and Ile-257 classified as group II, (iii) 37 isolates with Ile-257 termed group III, (iv) one isolate with Ile-257 and Gln-303 classified as group IV, and (v) 4 isolates with Met-203 and Ile-257 termed group V (group I-V as specified in Table 4).\n\nExcept for serotype 2 reference strain ATCC19414T, which revealed a unique pattern (Ile-55, Asn-70 and Ile-257) all other reference strains included (see Table 4) corresponded to one of the SpaA groups observed among the field isolates.\n\nNone of the SpaA groups correlated with a certain host type (mixed avian and mammalian).\n\nAs far as serotypes were available (n = 32; serotype 1a and 1b (n = 20); serotype 2 (n = 9), serotype N (n = 3), they also did not correlate with certain SpaA groups.\n\nIn group I, we observed both serotype 1a/b and serotype 2 strains and within group III, strains of serotypes 1a/b, 2 and N were present (data not shown).\n\nThe number of C-terminal tandem repeats of similar 20-amino-acid sequences in the SpaA proteins of field isolates ranged from 7 to 13, corresponding to the different spaA nucleotide sequence lengths observed.\n\nThe majority of strains (89.7%) harboured a domain with 9 repeats similar to that present in strain Fujisawa and in all SpaA-positive serotype reference strains, except for serotype 9 strain Kaparek (Table 4).\n\nThe remaining field isolates showed either higher or lower number of repeats.\n\nOne strain from a chicken with septicaemia was truncated by 40 amino acids at positions 502 and 534 and another seven strains lacked a 20 amino acids repeat either at position 534 or 558.\n\nSeven strains revealed 10 repeats and two porcine strains even showed 11 and 13 repetitions of similar 20-amino-acid sequences in the C-terminal part of their SpaA protein, respectively.\n\nA host-specific distribution of SpaA types was not observed.\n\nPortraying the different SpaA alleles against the phylogenetic background of the strains reveals a strong linkage of group I (amino acid changes Ile-55, Asn-70, Asp-178, Asn-195, Ile-257 and Gln-303 compared with Fujisawa strain) with ST complex 9 (Figure 2B).\n\nGroup II (Ser-101, Ile-257) and group III isolates (Ile-257) occur in several STs which are not related to this major ST complex.\n\nOnly in one case, different SpaA types occur in the same sequence type, namely ST48, which is made up by porcine isolates (Figure 2A).\n\nNucleotide sequence accession numbers\nNucleotide sequence of spaA genes of 165 E. rhusiopathiae strains have been submitted to the GenBank database under accession nos.\n\nKR606141 – KR606305.\n\nDiscussion\nAlthough there is an increasing notion of severe outbreaks of Erysipelas in poultry [10,22,47], possibly related to the ban of conventional cages within EU from 2012 and the large changes of housing systems due to welfare demands for laying hens [9,10,12], only little is known about the molecular epidemiology of avian E. rhusiopathiae isolates.\n\nTo overcome this, we investigated isolates of E. rhusiopathiae, mainly from poultry but also from mammalian hosts by a newly developed species-specific MLST scheme and in addition by more established methods such as PFGE, virulence genotyping and Spa typing.\n\nThe novel MLST scheme for E. rhusiopathiae is based on the identification of nucleotide polymorphisms of internal fragments from seven housekeeping genes involved in metabolic pathways of the bacterial pathogen.\n\nThe target genes were chosen with a dN/dS ratio of <1 to guarantee a very low degree of evolutionary pressure on the proteins and absence of a selective force on the respective gene locus.\n\nThis ratio was calculated for other MLST schemes, recently developed e.g.\n\nfor the bovine pathogen Mannheimia haemolytica [48] or for Enterococcus faecalis, which has been associated with amyloid arthropathy in chickens [49] as well.\n\nThe lower number of alleles in the E. rhusiopathiae MLST scheme, which varies between 6 (pta) and 14 (purA) among 165 E. rhusiopathiae strains together with a diversity of index D of 0.69 (95% CI, 0.579 to 0.775), which is also lower than that observed for other schemes [48-51] might indicate a lower diversity as compared e.g.\n\nto the Gram negative pathogen E. coli or to the Gram positive species Streptococcus gallolyticus.\n\nHowever, this assumption should be treated cautiously as the MLST databases of these two species contain significantly more isolates, i.e.\n\n7.500 isolates in case of Escherichia coli [52] and 292 isolates in case of Sc.\n\ngallolyticus [53].\n\nWhether E. rhusiopathiae would still appear as a bacterial species with low diversity after including more isolates from different sources remains to be determined.\n\nThe distribution of the STs as presented in a minimum spanning tree (MST) shows accumulations of E. rhusiopathiae strains isolated from various animals in certain STs (Figure 2A).\n\nEven if there was a bias towards avian isolates and towards isolates from Germany in our sample material, there was no indication for host or geographic specificity.\n\nStrains from poultry and swine randomly scattered throughout the MSTree and commonly shared identical STs, such as ST9, ST8 and ST5.\n\nThis might indicate that birds and pigs may be infected by phylogenetically similar strains either by a common reservoir or by direct or indirect transmission from one animal species to the other.\n\nA limited host specificity has also been suggested in another recent study, where marine E. rhusiopathiae isolates were shown to be capable of inducing classical skin lesions in pigs in a skin inoculation model [54].\n\nHowever, looking deeper into the clonal nature of our strains by PFGE, those from poultry and pigs were commonly found in same PFGE clusters, but no identical pairs of isolates were observed between the two species.\n\nThis supports a previous finding by Eriksson et al.\n\nwho also didn’t observe a 100% band profile identity among any of the pig and poultry isolates albeit the strains were not separated into two distinct populations by PFGE analysis [22].\n\nNotably, the most prominent ST observed in the present study – ST9 - includes human and animal strains.\n\nThe grouping of porcine strain ATCC 19414T and human strain IMT9137 in an identical sequence type and in the same PFGE cluster (89.9% similarity in banding pattern) indicates that these strains may be closely related and that a zoonotic potential of animals strains should be taken into consideration.\n\nSporadic diseases in humans have been reported and these often occurred in farmers and in other persons whose work is closely related with contaminated animals, underlining that E. rhusiopathiae infection in humans is occupationally-related [2,55,56].\n\nOverall, our MLST analysis distinguished 165 isolates into 72 sequence types (STs) and only partial congruence was observed to the grouping of strains into 58 PFGE clusters.\n\nMLST intends to portray the long term epidemiology and the evolutionary history of a bacterial pathogen based on a representative set of the bacterial core genome rather than to unravel disease outbreaks, at least not without additional typing methods [26].\n\nIn contrast, PFGE is a suitable tool to monitor short-term local outbreaks mainly by identifying clones [57].\n\nIn studies comparing MLST to PFGE e.g.\n\namong Enterococcus faecalis, Staphylococcus aureus, and Vibrio cholerae isolates, MLST has been found to have similar or greater discriminatory ability than PFGE [58-61].\n\nIn contrast, a study comparing MLST and PFGE data in Escherichia coli O157:H7, found that PFGE revealed a greater discriminatory ability than MLST did, which may be due to the highly clonal nature of this E. coli serotype [62].\n\nIn case of the Gram-negative pathogen Pseudomonas aeruginosa Johnson et al.\n\nfound that MLST was better for detecting genetic relatedness, while PFGE was more discriminatory than MLST for determining genetic differences in this bacterial species and to confirm the a patient-to-patient transmission [63].\n\nNemoy et al.\n\nobserved a greater discriminatory ability and reproducibility of MLST than PFGE for ESBL-producing E. coli [58].\n\nThey suggested MLST is suitable to a priori define genetically related bacterial strains, which might be very helpful for surveillance.\n\nOur MLST data for the first time allow determining E. rhusiopathiae as a weakly clonal species as 165 isolates are dispersed among 72 different sequence types.\n\nThe accumulation of a number of strains in ST complex 9 may indicate that this group of genetically related strains represents a particularly successful subpopulation.\n\nIf this holds true after including more strains from different countries is uncertain.\n\nLikewise, possible reasons for this success or at least high prevalence of STC9 strains (e.g.\n\nhigh virulence, environmental survival) also need to be studied.\n\nInterestingly, although serotypes for only 32 of our isolates were available (serotype 1a and 1b (n = 20); serotype 2 (n = 9); serotype N (n = 3)), these serotypes were not strictly linked with a certain sequence type or ST complex (data not shown).\n\nIn addition, different serotypes were observed in identical STs, indicating that the O antigen encoding genetic structure may have, at least partly, evolved independently from the phylogenetic background of the strains, which has likewise been reported for other bacterial species, such as E. coli and Bordetella spp.\n\n[64,65].\n\nNo correlation between serotype and PFGE pattern could also be observed in a recent study including E. rhusiopathiae isolates from poultry, pigs, emus, and the poultry red mite Dermanyssus gallinae [22].\n\nHere, the authors found that serotypes were randomly scattered throughout the dendrogram based on PFGE patterns and that isolates with the same PFGE pattern were of different serotypes in some cases.\n\nThey concluded that serotyping may be less suitable for studies on epidemiological relationships between flocks.\n\nConcerning the putative virulence genes investigated in our study, there was no congruence between one of these genes with a certain sequence type or PFGE cluster, which is primarily attributable to the frequent detection of the genes.\n\nAlmost all 16 markers selected and putatively involved in pathogenesis, except for intI (85.5%), the Alginate-O-acetyltransferase gene algI (97.6%), and the attachment protein gene dnaB (99.4%) were regularly present in our isolates.\n\nAccording to the annotation of whole genome sequenced E. rhusiopathiae strains Fujisawa (GenBank AP012027) and SY1027 (GenBank CP005079) intI encodes an internalin-like protein.\n\nWe observed 15% intI-negative isolates that occurred in 12 different STs, mostly from poultry and two isolates from sheep.\n\nBut, as the function of this internalin-like protein has been deduced from amino acid sequence comparisons only, further molecular genetic studies and in vitro assays would have to be performed to verify its putative role in E. rhusiopathiae pathogenesis.\n\nAlthough most of the other genes were regularly present in our isolates, their expression might vary due to different body compartments or environmental factors.\n\nFor some of these factors, such as the neuraminidase, a correlation between the produced amount of this enzyme, which may serve the nutritional requirements and play a role in adherence and antiphagocytic activity of the bacteria, and the virulence of strains has been reported [2,66].\n\nIt was not unexpected to detect the capsule biosynthesis locus in all our isolates.\n\nIn previous studies capsule-negative mutants or the loss of capsule in general resulted in avirulent strains which did not resist phagocytosis by murine polymorphonuclear leukocytes and lost the capability of intracellular survival [2,40].\n\nThus, such strains would not have been able to cause severe disease in the various hosts.\n\nThis study was mainly focussed on poultry isolates, as we intended to provide a rational typing method to assess the clonal relatedness of these strains, particularly with respect to the selection of epidemiological relevant strains to be included in future vaccines.\n\nIn this respect we also aimed to determine, whether the N-terminal hyper-variable region of the surface protein SpaA, which apart from SpaC, represents one of the most promising vaccine candidates [13-15] might show a co-evolution with the genomic backbone of E. rhusiopathiae.\n\nThe exclusive finding of SpaA and the absence of SpaB and SpaC in our sample collection might be due the prevalence of certain serotypes among our strains.\n\nOur partial serotype data confirm what has been reported in previous studies, namely that the spaA gene usually, but not exclusively, occurs in strains belonging to serotype 1a, 1b, 2, 5, 8, 9, 12, 15, 16, 17 and type N, while spaB and spaC are mainly observed in E. rhusiopathiae serotypes 4, 6, 11, 19, and 21 and in serotype 18, respectively [3,13,14,17].\n\nIngebritson et al.\n\nreported that one strain may contain more than one Spa type and that these were not always confined to a certain serotype [3].\n\nIt is not likely that single isolates of our study harboured different Spa types as this would have become apparent due to ambiguous sequencing data.\n\nDifferent authors have explored the variations in the N-terminal half of the spaA gene, particularly in the protective domain which is located at amino acid positions 30 to 413, and in the repeat domain which is located at amino acid positions 448 to 626 (in case of 8 to 10 tandem repeats) [14,67,68].\n\nA broad collection of avian isolates and their spa gene has not been investigated so far, limiting our knowledge about the diversity of this major antigen considerably.\n\nBy sequence analysis of the spaA gene of 165 clinical E. rhusiopathiae isolates, thereof 120 from birds, we found high sequence identity within the signal sequence region, located at the most N-terminal part of the Spa protein, corroborating the findings of To and Nagai and supporting the idea that Spa proteins may cross bacterial cell membranes and eventually be secreted from the bacterial cell by using a secretion machinery commonly present in E. rhusiopathiae strains [14].\n\nAlthough most of our isolates (89.7%) revealed nine C-terminal tandem repeats in their SpaA protein, which is also common to most of the serotype reference strains investigated by To and Nagai and listed in Table 4 [14], the diversity in number was quite high with 7 to 13 tandem repeats and has not been reported before.\n\nAs this repeat domain has been suggested to function as an anchor for binding Spa proteins tightly to the bacterial surface it remains to be determined, e.g.\n\nby in vitro adhesion experiments, if this binding might perhaps be influenced by the number of repeats [13,14,68].\n\nRegarding the amino acid substitutions in the N-terminal protective part of the Spa protein we detected five different variants (group I-V) that occurred independently of the original host species and have been described at least in part in previous publications on porcine isolates as well.\n\nAmong swine isolates from Japan, Uchiyama et al.\n\nobserved three groups, looking at substitutions at amino acid positions 195, 203 and 257 [17].\n\nThese positions were also part of our investigations, while we additionally included another 6 amino acid substitutions resulting in a finer resolution of the groups.\n\nThus, their group 2 resembles our groups II-IV; group 1 matches with our group V; and group 3 was not detected among our isolates at all.\n\nIn that study, more than half of the 34 porcine strains showed the Met-203 variant in combination with Ile-257 (group 1 according to Uchiyama et al.\n\n[17]), corresponding to group 2 recently determined among another collection of isolates from Japan [69].\n\nTo et al.\n\n[68] found that 95% of their overall 80 pig isolates carried the Met-203 variant of the spaA, while the same variant accounted for 55.6% of the isolates included by Uchiyama et al.\n\n[17].\n\nNotably, we observed this variant only very infrequently (2.4%) among our isolates.\n\nIn the present strain collection we rather detected SpaA variants (group I, 52.7%; group II, 21.8%; group III, 22.4%) that have been described for different serotype reference strains before (Table 4) [14].\n\nOf note, the distribution of spaA variants demonstrated to be irrespective of the original host of the strains, i.e.\n\navian or mammalian.\n\nWhether the current geographic linkage of the Met-203 variant to Japan remains after studying more isolates from different countries is uncertain [17,69].\n\nUchiyama et al.\n\ncould show that isolates with Met-203 were highly pathogenic in mice with LD50 values between 0.45 and 1.45 CFU/mouse, but comparative in vivo data with isolates representing other spaA groups were not provided [17].\n\nThe same authors showed that the commercial vaccine Koganei 65–0.15, which lacks this amino acid substitution, was still protective against an experimental infection of pigs with a Met-203 variant.\n\nThus, it was concluded that the respective protein region might not be that essential for protection against E. rhusiopathiae infections [17].\n\nOur analysis was based on a comparison with the Fujisawa serotype 1a strain to allow for a comparison with already published data, that also used this strain as reference [17,67,69].\n\nAs we did not have access to one of the vaccine strains (inactivated whole cell bacteria) currently used in the field in Germany for protection of swine against Erysipelas, a comparison of our strain collection with these strains still has to be done.\n\nMoreover, targeted virulence assays including the most prominent sequence types and different spaA variants might provide important insight into the impact of a strain’s genetic background and its potential to cause disease.\n\nIn summary, with the development of the MLST scheme a highly reproducible epidemiological tool to study E. rhusiopathiae strains has been established that allows for long-term global studies to assess the evolutionary history and genetic relatedness of isolates belonging to this bacterial pathogen.\n\nClinical isolates were found to be highly clonal on the one hand (ST complex 9) but also scattered around the entire population of the selected collection.\n\nApplying this MLST technique clearly unravelled a common evolutionary origin of isolates obtained both from avian and mammalian hosts indicating an interspecies transmission and/or common reservoir and a zoonotic potential.\n\nCombined data of MLST, PFGE and SpaA typing provided a good basis for assessing the clonal diversity and molecular make-up of E. rhusiopathiae.\n\nThis might be very advantageous in several aspects, including the (i) selection of epidemiological relevant vaccine candidates (ii) estimation of the pathogenic relevance of single putative virulence genes and isolates in future in vitro and in vivo experiments, and (iii) the assessment of the zoonotic risk of the pathogen.\n\n----------\nAs a professional microbiologist, create a concise and comprehensive Chinese scientific report on Erysipelothrix Spp. research based on the provided text, whether it's an article, post, conversation, or passage. Follow these guidelines:\n\n 1. Produce a detailed and in-depth report that remains clear and concise.\n 2. Focus on main ideas and essential information, removing any extraneous language.\n 3. Strictly rely on the provided text without adding external information.\n 4. Format the report in paragraphs for easy understanding.\n 5. Conclude with “[End of Notes, Message #X],” where “X” represents the total number of messages I’ve sent. Increment the message counter with each new message.\n 6. Use English for technical terms, industry terminology, proper nouns, and species names. After you finish, add the following words: {{{ I_finished_papa!!! }}} to the end of you answer
- Assistant
Erysipelothrix spp. 研究报告
简介
Erysipelothrix rhusiopathiae 感染在家禽行业中重新引起了广泛关注。与猪源分离株相比,禽类 E. rhusiopathiae 分离株的分子流行病学特征尚不明确。本研究旨在开发 E. rhusiopathiae 的多位点序列分型 (MLST) 方案,研究基于脉冲场凝胶电泳 (PFGE) 和 MLST 的菌株分组一致性,确定主要免疫原性蛋白 SpaA 的多样性,并检查与 virulence 相关的基因在来自家禽、猪和其他宿主(包括人类)的野外分离株中的分布。
材料与方法
本研究共纳入 165 个 E. rhusiopathiae 分离株,主要来自德国(136 个)及其他国家(29 个),重点关注禽类来源的分离株(鸡 71 个,火鸡 43 个,其他鸟类 6 个),同时也包括猪(36 个)和其他动物(6 个)及人类(3 个)分离株。使用七个 housekeeping 基因进行 MLST 分析,确定了 72 个序列类型(STs),显示出整体高多样性,其中 34.5% 的分离株属于一个主要的 ST 复合体 STC9。
结果
PFGE 分析显示 58 个不同的簇,且基于序列的 MLST 方法与 PFGE 的一致性不高。根据 SpaA 的 N 端超可变区的多态性,分离株被分类为五组,反映了菌株的系统发育背景。超过 90% 的分离株携带所有 16 个假定的 virulence 基因,只有 intI 基因的分布较少。MLST 数据表明 E. rhusiopathiae 是一种弱克隆物种,具有有限的宿主特异性。
讨论
尽管近年来家禽中 Erysipelas 的严重爆发有所增加,但对禽类 E. rhusiopathiae 分离株的分子流行病学了解甚少。本研究通过开发 MLST 方案,结合 PFGE、virulence 基因分型和 Spa 分型,深入探讨了 E. rhusiopathiae 的种群结构。结果显示,E. rhusiopathiae 分离株在不同宿主间存在共同的进化起源,表明了跨物种传播和潜在的 zoonotic 风险。
结论
本研究建立的 MLST 方案为 E. rhusiopathiae 的流行病学研究提供了一个高度可重复的工具,能够评估该细菌病原体的进化历史和遗传相关性。结合 MLST、PFGE 和 SpaA 分型的数据为评估 E. rhusiopathiae 的克隆多样性和分子组成提供了良好的基础,这对未来疫苗候选者的选择、单个假定 virulence 基因的致病相关性评估以及病原体的 zoonotic 风险评估均具有重要意义。
[End of Notes, Message #2] {{{ I_finished_papa!!! }}}